Dow Up 0.11% Nasdaq Up 0.50%

Antares Pharma Inc. (ATRS)

-NasdaqCM
2.35 0.22(10.33%) Aug 29, 3:59PM EDT
Prev Close:2.13
Open:2.12
Bid:2.28 x 500
Ask:2.34 x 2000
1y Target Est:5.33
Beta:0.85
Earnings Date:Nov 4 - Nov 10 (Est.)
Day's Range:2.12 - 2.37
52wk Range:1.87 - 5.15
Volume:2,113,910
Avg Vol (3m):1,321,670
Market Cap:306.60M
P/E (ttm):N/A
EPS (ttm):-0.20
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ATRS

Comparison

Symbol% ChgMkt Cap
ATRSUp 10.33%306.60M
BDX22.48B
BJCT7.12M

Key Statistics

Forward P/E (1 yr):47.00
P/S (ttm):12.76
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.24
Quarterly EPS Est (Sep-14) :-0.06
Mean Recommendation*:1.0
PEG Ratio (5 yr expected):-0.12

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Antares Pharma, Inc. operates as a specialty pharmaceutical company that focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies worldwide. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback